SAMANTHA STRATTON: Open Payments
NPI 1336413095 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,817 in 173 payments from 16 companies in 2025. Trend: 2023 $1,218 · 2024 $1,860 · 2025 $2,817
Food & beverage: $2,590Education: $227
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $418 |
| GENZYME CORPORATION | 17 | $374 |
| Novartis Pharmaceuticals Corporation | 24 | $343 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $284 |
| Janssen Biotech, Inc. | 12 | $260 |
| UCB, Inc. | 21 | $210 |
| Regeneron Healthcare Solutions, Inc. | 10 | $210 |
| Amgen Inc. | 6 | $157 |
| Galderma Laboratories, L.P. | 23 | $147 |
| Organon LLC | 9 | $108 |
Products named: DUPIXENT, COSENTYX, TREMFYA, SKYRIZI, Bimzelx, ILUMYA, RINVOQ, OTEZLA.
Industry payments across KY — which companies pay providers there.
